MAPT and Alzheimer disease: This set of behavioral results suggests that synaptic defects occurring in AD, and here exemplified by a reduction in Shank3a, may synergize with classical Aβ/tau neuropathologies to aggravate the clinical mnemonic and anxiety symptoms of AD.